Skip to content

Safety Study of Dexmedetomidine in Elderly Under General Anesthesia

Effects of Dexmedetomidine at Different Doses on Hemodynamics and Recovery Quality in Elderly Patients Undergoing Hip Replacement Surgery Under General Anesthesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05567523
Enrollment
200
Registered
2022-10-05
Start date
2019-06-01
Completion date
2022-03-30
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Disease, Hip Fractures

Keywords

Dexmedetomidine, Elderly, Hemodynamics, Hip replacement, General anesthesia

Brief summary

The purpose of this study is to find out appropriate dose range of dexmedetomidine to provide the elderly patients satisfactory sedation and analgesia with stable hemodynamics during perioperative period of hip replacement under general anesthesia.

Detailed description

All patients will be screened to determine eligibility for study entry, and the patients who meet the eligibility requirements will be informed about the study and potential risks. After giving written informed consent, the patients will be randomized into different doses of dexmedetomidine groups and the comparative groups in a same ratio.

Interventions

DRUGDexmedetomidine

In dexmedetomidine groups, patients will be pumped 0.1ml/kg of dexmedetomidine (contained dexmedetomidine 0.25/0.5/0.75µg/kg in Group D0.25/D0.5/D0.75) for 15min before anesthesia induction, following continuous infusion at the rate of 0.125ml/kg/h until the end of operation.

DRUGNormal saline

normal saline

DRUGMidazolam

midazolam

Sponsors

Zhenjiang First People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* age ≥65yr, American Society of Anesthesiologists (ASA) physical status scale grade I-III, ready for HP; body weight between 45 and 75kg, body mass index (BMI) between 18 and 24kg/m2; * the health conditions generally well according to medical history, physical examination, and laboratory tests; * no signs of difficult intubation; * no history of dementia and mental problems; * normal cognitive function, ability to understand and comply with study procedures.

Exclusion criteria

* Age \<65 yr or \>90 yr; BMI greater than 24 kg/m2; ASA grade higher than III; * Heart failure, severe arrhythmias, severe bradycardia (heart rate less than 40 beats/min), atrioventricular block of degree 2 or above, sick sinus syndrome, systolic blood pressure (SBP) ≥180 or \<90 mmHg, diastolic blood pressure (DBP) ≥110 or \<60 mmHg; * Severe liver or kidney dysfunction, severe infection, and other pathological conditions that interfere with study results. * Dementia, cerebrovascular accidents within 3 months, mental illness, epilepsy, and other adverse events that interfere with study results. * Patients with the conditions that block communication and preoperative assessment, such as serious hearing or visual impairment; * History of chronic analgesic use, long-term psychotropic medication use, alcohol or drug addiction.

Design outcomes

Primary

MeasureTime frameDescription
Changes of baseline blood pressureThrough the whole perioperative period, an average of 10 hoursChanges of baseline blood pressure in each group, including systolic blood pressure, diastolic blood pressure and mean arterial pressure
Changes of baseline heart rateThrough the whole perioperative period, an average of 10 hoursChanges of baseline heart rate in each group
Numbers of elderly patients with hypotensionThrough the whole perioperative period, an average of 10 hoursHypotension is defined as systolic blood pressure \<90 mmHg or mean arterial pressure below \>20% of basal values.
Numbers of elderly patients with bradycardiaThrough the whole perioperative period, an average of 10 hoursBradycardia is defined as heart rate \<50 beats/min or below \>20% of basal values.

Secondary

MeasureTime frameDescription
Sedation changes after general anesthesia using Richmond agitation-sedation scalebefore general anesthesia, up to 2 hours after general anesthesiaSedation changes after general anesthesia using Richmond agitation-sedation scale(-5 to +4, 0 means awake and quiet) in each group
Pain changes after general anesthesia using visual analogue scalebefore general anesthesia, up to 2 hours after general anesthesiaPain changes after general anesthesia using visual analogue scale(0 to 10,higher scores mean a worse outcome) in each group

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026